Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
---|---|
Enthalten in: |
Kidney international reports - 7(2022), 11 vom: 01. Nov., Seite 2539-2540 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Izzedine, Hassan [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 21.12.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.ekir.2022.09.004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM350437017 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM350437017 | ||
003 | DE-627 | ||
005 | 20231226045009.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ekir.2022.09.004 |2 doi | |
028 | 5 | 2 | |a pubmed24n1168.xml |
035 | |a (DE-627)NLM350437017 | ||
035 | |a (NLM)36531874 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Izzedine, Hassan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 21.12.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Brocheriou, Isabelle |e verfasserin |4 aut | |
700 | 1 | |a Mathian, Alexis |e verfasserin |4 aut | |
700 | 1 | |a Ghez, David |e verfasserin |4 aut | |
700 | 1 | |a Amoura, Zahir |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Kidney international reports |d 2016 |g 7(2022), 11 vom: 01. Nov., Seite 2539-2540 |w (DE-627)NLM264185072 |x 2468-0249 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2022 |g number:11 |g day:01 |g month:11 |g pages:2539-2540 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ekir.2022.09.004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 7 |j 2022 |e 11 |b 01 |c 11 |h 2539-2540 |